Predicting response to PD-1 inhibitors in head and neck squamous cell carcinomas using peripheral blood inflammatory markers
Immune checkpoint inhibitor (ICI) treatment has the potential to induce durable disease remission. However, the current combined positive score (CPS) is insufficient accurate for predicting which patients will benefit from it. In the present study, a real-world retrospective study was conducted on 5...
Saved in:
| Main Authors: | Ruihua Fang, Yi Chen, Bixue Huang, Zhangfeng Wang, Xiaolin Zhu, Dawei Liu, Wei Sun, Lin Chen, Minjuan Zhang, Kexing Lyu, Wenbin Lei |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Translational Oncology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523324003486 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prosaposin – A plausible biomarker in head and neck squamous cell carcinoma
by: Avradeep Datta, et al.
Published: (2024-03-01) -
Immunosuppression and Outcomes in Patients with Cutaneous Squamous Cell Carcinoma of the Head and Neck
by: Doriana Iancu, et al.
Published: (2025-01-01) -
The potential of hydrogel‐free tumoroids in head and neck squamous cell carcinoma
by: Michael Wong, et al.
Published: (2024-08-01) -
Natural killer cell in the development and treatment of head and neck squamous cell carcinoma
by: Lu-Ming WANG, et al.
Published: (2021-02-01) -
Multi-omics approach reveals promising salivary protein markers for head and neck squamous cell carcinoma prognosis
by: Oriana Barros, et al.
Published: (2023-09-01)